Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03170388 · ClinicalTrials.gov registry record · Phase 2
A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris
A Phase 2 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 2
- Development phase
- 741
- Enrollment target
NCT03170388 is a Phase 2 study that has completed, run by Bausch Health Americas. The registered enrollment target is 741 participants.
The verdict
NCT03170388, a Phase 2 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 741 participants
- Enrollment target
Study Summary
A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris
Interventions
- DRUG IDP-126 Gel
- DRUG IDP-126 Vehicle Gel
- DRUG IDP-126 Component A
- DRUG IDP-126 Component B
- DRUG IDP-126 Component C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 741 participants |
| Start Date | 2017-10-05 |
| Est. Completion | 2019-04-23 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03170388
The ClinicalTrials.gov registry entry for NCT03170388 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 741 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which IDP-126 Gel is the first listed.
NCT03170388 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03170388 about?
NCT03170388 is a clinical study titled "A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris". A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris
What is the current status of trial NCT03170388?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 741 participants. The study started on 2017-10-05. Estimated completion is 2019-04-23.
What interventions are being tested in trial NCT03170388?
The interventions under investigation include: IDP-126 Gel (DRUG), IDP-126 Vehicle Gel (DRUG), IDP-126 Component A (DRUG), IDP-126 Component B (DRUG), IDP-126 Component C (DRUG).
Who is sponsoring clinical trial NCT03170388?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.